• WijdicksEelco F MEFM0000-0001-9807-9172Division of Neurocritical Care and Hospital Neurology, Mayo Clinic, Rochester, Minnesota, USA..
• Division of Neurocritical Care and Hospital Neurology, Mayo Clinic, Rochester, Minnesota, USA.
• J. Intern. Med. 2022 Dec 1; 292 (6): 846857846-857.

AbstractMetabolic derangements, when acute and severe, affect brain function. This presents mostly with a marked decline in the level of consciousness, resulting in impaired responsiveness, abnormal receptivity, impaired content, and loss of memory retention. The term metabolic encephalopathy has been used but is conjecture that can be challenged in the age of modern neuroimaging. We now recognize that many metabolic encephalopathies may involve structural lesions and at an early stage. Common clinical conundrums are the evaluation of the degree of brain injury and its recoverability. This review discusses the appropriate terminology for these conditions, the diagnostic approach, therapy recommendations, and prediction of recovery potential. In evaluating a presumed metabolic cause for encephalopathy, we must (1) search for and rule out structural injury to the brain despite an obvious explanatory metabolic derangement, (2) recognize that several confounding conditions often co-exist, and (3) acknowledge that resolution of brain dysfunction may be protracted despite normalization of laboratory values.© 2022 The Association for the Publication of the Journal of Internal Medicine.

18 keywords...

hide…